Okay, let's tackle this question. The question is about why neostigmine can't cross the blood-brain barrier. The options are missing, but I need to figure out the correct answer based on pharmacological principles.

First, I recall that the blood-brain barrier is selective. It allows small, lipid-soluble molecules to pass through while keeping out larger or more polar substances. Neostigmine is a cholinesterase inhibitor. Wait, but there are different types of cholinesterase inhibitors. Pyridostigmine, for example, can cross the BBB, but neostigmine can't. So why is that?

Looking at the chemical structure: Neostigmine has a quaternary ammonium group. Quaternary ammonium compounds are positively charged, which makes them highly polar. Polar molecules can't passively diffuse through the lipid membranes of the blood-brain barrier. In contrast, tertiary amines like pyridostigmine have a nitrogen with three bonds and a lone pair, allowing them to be uncharged in certain pH conditions, making them lipid-soluble enough to cross.

So the correct answer is likely related to the quaternary ammonium structure. Let's check the options. The options might be about molecular weight, ionization, or structure type. The key point is the quaternary ammonium ion making it polar and unable to cross.

Now, for the other options. If another option mentions ionization state, like being ionized, that's part of it. But the primary reason is the quaternary structure. Other incorrect options might mention molecular weight (but neostigmine isn't that large), or maybe lipid solubility, but the main issue is the charge due to quaternary ammonium.

Clinical pearl: Remember that quaternary ammonium compounds (like neostigmine) can't cross the BBB, which is why they're used peripherally for myasthenia gravis without CNS effects. Tertiary amines like pyridostigmine are preferred when CNS effects are needed.

So the correct answer is the one stating the quaternary ammonium structure. The options might have choices like "Quaternary ammonium structure" vs "Tertiary amine structure" or "High molecular weight" or "Low lipid solubility". The main reason is the quaternary ammonium making it ionized and polar.

**Core Concept**
Neostigmine is a cholinesterase inhibitor with a quaternary ammonium structure, which restricts its ability to cross the blood-brain barrier (BBB) due to its high polarity and charge. The BBB preferentially allows lipid-soluble, uncharged molecules to passively diffuse into the central nervous system (CNS).

**Why the Correct Answer is Right**
Neostigmine contains a **quaternary ammonium group**, which is permanently charged and highly hydrophilic. This structure prevents passive diffusion across lipid-rich membranes like the BBB. In contrast, tertiary amines (e.g., pyridostigmine) can cross the BBB because they are uncharged in physiological pH and lipid-soluble. The quaternary ammonium charge creates steric and electrostatic barriers to BBB penetration.

**Why Each Wrong Option is Incorrect**
**Option A:** *"High molecular weight"* — Incorrect. Neostigmine’s

✓ Correct Answer: D. Quarternary structure